日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

[Retracted] EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas

【已撤稿】EGFR表达与CXCR4胞质染色相关，并可预测三阴性乳腺癌预后不良。

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2026.15503
Li, Rong-Hui; Huang, Wen-He; Wu, Jun-Dong; Du, Cai-Wen; Zhang, Guo-Jun
肿瘤
肿瘤免疫
EGF
CXCR4
乳腺癌
EGFR
发表日期：2026
文献求助 收藏

Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer

持续使用安罗替尼联合口服长春瑞滨治疗难治性HER2阴性晚期乳腺癌已显示出抗肿瘤疗效

期刊:Breast Cancer-Targets and Therapy
影响因子:3.4
doi:10.2147/BCTT.S534082
Huang, Jia-Yi; Zhang, Yan; Du, Cai-Wen
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer

低剂量阿帕替尼联合口服长春瑞滨治疗既往接受过治疗的HER2阴性转移性乳腺癌的疗效和安全性

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7181
Huang, Jia-Yi; Chen, Xue-Lian; Xie, Xiao-Feng; Song, Lin; Chen, Li-Ping; Lan, Xiao-Feng; Bai, Xue; Chen, Xiao; Du, Cai-Wen
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer

一项单臂 II 期临床试验，研究安罗替尼联合化疗治疗转移性三阴性乳腺癌的疗效

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1122294
Huang, Jia-Yi; Xie, Xiao-Feng; Chen, Xue-Lian; Zhang, Qiu-Yi; Chen, Li-Ping; Bai, Xue; Lan, Xiao-Feng; Song, Lin; Guo, Jin-Feng; Du, Cai-Wen
乳腺癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial

吡咯替尼联合曲妥珠单抗和化疗治疗人表皮生长因子受体2阳性转移性乳腺癌：一项单臂探索性II期试验

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06770-6
Xie, Xiao-Feng; Zhang, Qiu-Yi; Huang, Jia-Yi; Chen, Li-Ping; Lan, Xiao-Feng; Bai, Xue; Song, Lin; Xiong, Shui-Ling; Guo, Si-Jia; Du, Cai-Wen
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Acute-on-chronic liver failure following eribulin treatment for metastatic breast cancer: a case report

转移性乳腺癌患者接受艾立布林治疗后发生急性加重型慢性肝衰竭：病例报告

期刊:Journal of International Medical Research
影响因子:1.5
doi:10.1177/03000605221090097
Xie, Xiao-Feng; Huang, Jia-Yi; Chen, Li-Ping; Lan, Xiao-Feng; Zhang, Qiu-Yi; Song, Lin; Bai, Xue-; Du, Cai-Wen
肿瘤
肿瘤免疫
乳腺癌
肝衰竭
毒理研究
发表日期：2022
文献求助 收藏

Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression

Notch3通过一种新的机制抑制乳腺癌中的上皮-间质转化，即上调GATA-3的表达。

期刊:Oncogenesis
影响因子:6.4
doi:10.1038/s41389-018-0069-z
Lin, Hao-Yu; Liang, Yuan-Ke; Dou, Xiao-Wei; Chen, Chun-Fa; Wei, Xiao-Long; Zeng, De; Bai, Jing-Wen; Guo, Yu-Xian; Lin, Fang-Fang; Huang, Wen-He; Du, Cai-Wen; Li, Yao-Chen; Chen, Min; Zhang, Guo-Jun
肿瘤
肿瘤免疫
Notch
乳腺癌
GATA
GATA-3
Notch3
发表日期：2018
文献求助 收藏

The association between Notch4 expression, and clinicopathological characteristics and clinical outcomes in patients with breast cancer

Notch4表达与乳腺癌患者的临床病理特征和临床结局之间的关联

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2018.8442
Wang, Jing-Wei; Wei, Xiao-Long; Dou, Xiao-Wei; Huang, Wen-He; Du, Cai-Wen; Zhang, Guo-Jun
肿瘤
肿瘤免疫
Notch
乳腺癌
Notch4
发表日期：2018
文献求助 收藏

EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas.

EGFR 表达与 CXCR4 的细胞质染色相关，并预示着三阴性乳腺癌预后不良

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2016.5489
Li Rong-Hui, Huang Wen-He, Wu Jun-Dong, Du Cai-Wen, Zhang Guo-Jun
细胞生物学
EGFR
肿瘤免疫
发表日期：2017
文献求助 收藏